TrialLancet (London, England)2018

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

Christopher C Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.